60
Discover us

27 March 2025

The top three most ordered molecules on opnMe in 2024 have one thing in common. They all emerged from a research collaboration between the Centre of Targeted Protein Degradation (CeTPD) at the University of Dundee and Boehringer Ingelheim.

34
Discover us

10 February 2025

Read the full interview with Deepa Ghosh, Professor at the Institute of Nano Science and Technology in India, who talks about her experience with opnMe and the importance of open innovation in her work and how it is driving her research in osteoarthritis (OA).

62
Discover us

18 December 2024

Don’t miss the chance to connect with other scientists and researchers in the life science community at Boehringer Ingelheim’s Transforming Science Day at the European Molecular Biology Laboratory (EMBL) campus in Heidelberg on February 25, 2025.

48
PostDoc Grants

06 January 2025

We are excited to offer an exceptional PostDoc grant opportunity in the cutting-edge field of parapoxvirus-based cancer vaccines. This unique chance offers high-class talents the opportunity to execute their postdoctoral project proposal in the state-of-the-art scientific environment of the DNA Virus team at ViraTherapeutics, a subsidiary of Boehringer Ingelheim, located in Innsbruck, Austria for up to three years.

43
Discover us

06 January 2025

Are you prepared to elevate your career to new heights? We invite you to join us in Innsbruck, a place where cutting-edge innovation harmoniously coexists with the breathtaking beauty of the Austrian Alps. Our state-of-the-art facilities at ViraTherapeutics, coupled with a dynamic work culture, make Innsbruck an ideal location for both professional growth and personal enrichment.

Discover us

Hear from our collaborators

slide 1 to 2 of 13